Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors

Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors is a paper indexed in PICO Portal from OpenAlex.

How many citations does Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors have?

Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors has 458 citations in the OpenAlex counts PICO Portal stores.

When was Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors published?

Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors has 2011 year in the PICO Portal index.

What is the open-access status of Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors?

Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors has hybrid oa status in the PICO Portal index.

What is the DOI of Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors?

The DOI for Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors is on the source record.

What is the PMID of Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors?

The PMID for Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors is on the source record.

What is the OpenAlex record for Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors?

The OpenAlex for Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors is on the source record.